PF-Atlas › Clinical Trials › NCT02342964
Comparison of Non-invasive Measurement Methods of Hepatic Fibrosis in Cystic Fibrosis
Measure of hepatic elasticity · Not specified
Registry ID
NCT02342964
Phase
Not specified
Status
Completed
Drug / intervention
Measure of hepatic elasticity
Sponsor
Assistance Publique - Hôpitaux de Paris
Start
2015-01-08
Enrollment
56
Locations
1
About this trial
Non-invasive methods of the quantification of fibrosis may help to assess the development of fibrosis at a specific moment of the evolution of the disease, in the order to decide the initiation of treatment with ursodeoxycholic acid which may slow the progression to hepatic cirrhosis: * FibroTest, * The ultrasound impulse elastography, Fibroscan (FS) * Ultrasound Elastography by ShearWave (SWE) * Magnetic resonance elastography (MRE). The purpose of this study is to assess the contribution of these methods in the diagnosis of hepatic fibrosis during the evolution of the cystic fibrosis.
Explore related
Medical disclaimer. This page summarizes public trial data for NCT02342964 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.